TNF and psoriasis: Psoriasis patients receiving biologic agents including TNF-α inhibitors showed almost no difference in the progression of asymptomatic coronary artery diseases (CAD) in a follow up, while CT imaging data suggested a significant increase in the procession of CAD in the control group (Herédi et al., 2016).